H. TRIVEDI, M.B., F.R.C.P.(C); S. KUMAR, M.D.
To the editor: We have read the first report of ''Renal Transplantation in Multiple Myeloma" by Humphrey and associates (Ann Intern Med 83:651-653, 1975). This paper adds one more cause of end-stage renal disease in which transplantation can be done. The authors' logic for a transplant in a patient who has lethal disease is twisted. The logic of the argument is that myeloma patients who respond to chemotherapy have a median survival of approximately 40 months, and survival of cadaver human renal transplantation is 50% in approximately 2 years; therefore it is justified to prolong their life up to 40
TRIVEDI H, KUMAR S. Renal Transplantation in Lethal Disease. Ann Intern Med. ;85:132–133. doi: 10.7326/0003-4819-85-1-132_2
Download citation file:
Published: Ann Intern Med. 1976;85(1):132-133.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use